PFWA
SAGE

Paces Ferry Wealth Advisors’s Sage Therapeutics SAGE Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15
Closed -$1K – 917
2020
Q3 		$1K Buy
+15
New +$760 ﹤0.01% 947

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paces Ferry Wealth Advisors's SAGE Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of Sage Therapeutics (SAGE) in Q4 2020, closing a stake of 15 shares — an estimated $1K sold.

Paces Ferry Wealth Advisors first reported a position in SAGE in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 248 funds tracked by Wall St. Rank hold SAGE as of Q4 2020.

  • Paces Ferry Wealth Advisors reported no remaining Sage Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 15 Sage Therapeutics shares in Q4 2020, an estimated $1K.
  • Paces Ferry Wealth Advisors first reported a position in Sage Therapeutics in Q3 2020 and held it in 1 quarter.
  • Paces Ferry Wealth Advisors's Sage Therapeutics position peaked at $1K in Q3 2020.
  • 248 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.